These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27598772)

  • 1. Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF.
    Edinger N; Lebendiker M; Klein S; Zigler M; Langut Y; Levitzki A
    PLoS One; 2016; 11(9):e0162321. PubMed ID: 27598772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in mice.
    Shir A; Ogris M; Roedl W; Wagner E; Levitzki A
    Clin Cancer Res; 2011 Mar; 17(5):1033-43. PubMed ID: 21196415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors.
    Abourbeh G; Shir A; Mishani E; Ogris M; Rödl W; Wagner E; Levitzki A
    IUBMB Life; 2012 Apr; 64(4):324-30. PubMed ID: 22362419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses.
    Langut Y; Edinger N; Flashner-Abramson E; Melamed-Book N; Lebendiker M; Levi-Kalisman Y; Klein S; Levitzki A
    Oncotarget; 2017 Apr; 8(15):24046-24062. PubMed ID: 28445962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice.
    Langut Y; Talhami A; Mamidi S; Shir A; Zigler M; Joubran S; Sagalov A; Flashner-Abramson E; Edinger N; Klein S; Levitzki A
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13655-13660. PubMed ID: 29229829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of targeted activation of protein kinase PKR on proliferation of leukemia cell line K562 and its mechanism].
    Zhao SQ; Feng WL; Zeng JM; Bai WJ; Wang XZ; Wen JP; Cao WX; Luo YP; Huang ZG
    Ai Zheng; 2007 Oct; 26(10):1058-63. PubMed ID: 17927873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.
    Shir A; Ogris M; Wagner E; Levitzki A
    PLoS Med; 2006 Jan; 3(1):e6. PubMed ID: 16318410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation.
    Schmidt SV; Seibert S; Walch-Rückheim B; Vicinus B; Kamionka EM; Pahne-Zeppenfeld J; Solomayer EF; Kim YJ; Bohle RM; Smola S
    Oncotarget; 2015 Apr; 6(11):8635-47. PubMed ID: 25888634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein.
    Chandler LA; Sosnowski BA; McDonald JR; Price JE; Aukerman SL; Baird A; Pierce GF; Houston LL
    Int J Cancer; 1998 Sep; 78(1):106-11. PubMed ID: 9724101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of the growth-inhibitory effect of the RNase-EGF fused protein against EGFR-overexpressing cells.
    Hoshimoto S; Ueda M; Jinno H; Kitajima M; Futami J; Seno M
    Anticancer Res; 2006; 26(2A):857-63. PubMed ID: 16619480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
    Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
    Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF-mCherry Fusion Protein Expressed in E. coli Shows Product Heterogeneity but a High Biological Activity.
    Feiner RC; Pennè I; Müller B; Müller KM
    Biochemistry; 2019 Feb; 58(8):1043-1047. PubMed ID: 30735360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and cytotoxicity of fusion proteins of EGF and angiogenin.
    Yoon JM; Han SH; Kown OB; Kim SH; Park MH; Kim BK
    Life Sci; 1999; 64(16):1435-45. PubMed ID: 10321723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of a novel target fusion protein and its application in anti-tumor therapy.
    Sun R; Zhu Y; Feng H; Yang Z; Bian X; Gu P; Wang C; Liu Y
    Cell Physiol Biochem; 2015; 35(5):1877-91. PubMed ID: 25871436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity.
    Sato K; Nakamura T; Mizuguchi M; Miura K; Tada M; Aizawa T; Gomi T; Miyamoto K; Kawano K
    FEBS Lett; 2003 Oct; 553(3):232-8. PubMed ID: 14572630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eukaryotic expression and tumor-targeting modification of human mutated-IL-18 fusion gene].
    Lü JX; Peng Y; Meng ZF
    Yi Chuan; 2005 Jul; 27(4):557-60. PubMed ID: 16120577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of EGFP-EGF fusions to explore mechanism of endocytosis of epidermal growth factor.
    Jiang H; Zhang J; Shi BZ; Xu YH; Li ZH; Gu JR
    Acta Pharmacol Sin; 2007 Jan; 28(1):111-7. PubMed ID: 17184590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a fusion protein containing human epidermal growth factor and the collagen-binding domain of Vibrio mimicus metalloprotease.
    Kim DG; Min MK; Ahn SC; Kim JK; Kong IS
    Biotechnol Lett; 2009 Feb; 31(2):259-64. PubMed ID: 18931974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pancreatic RNase1-human epidermal growth factor fusion: an entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomas.
    Psarras K; Ueda M; Yamamura T; Ozawa S; Kitajima M; Aiso S; Komatsu S; Seno M
    Protein Eng; 1998 Dec; 11(12):1285-92. PubMed ID: 9930679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
    Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
    J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.